Table 2.
Clinicopathological characteristics of gynecological cancer patient samples.
| Histological Type | Endometrial Clear Cell Carcinoma | Endometrial Endometrioid Carcinoma | HG-EMCA | HG-SOC | Ovarian Endometroid Carcinoma |
|---|---|---|---|---|---|
| Number of Patients | 3 | 18 | 6 | 16 | 2 |
| Tumor Grade (%) | |||||
| FIGO grade 1 | 5 (27.8) | 0 | |||
| FIGO grade 2 | 5 (27.8) | 0 | |||
| FIGO grade 3 | 8 (44.4) | 2 (100) | |||
| High grade | 3 (100) | 6 (100) | 16 (100) | ||
| Tumor Stage (ratio) | |||||
| I | 2 (2/3) | 9 (9/17) | 2 (2/6) | 0 | 1 (1/2) |
| II | 0 | 1 (1/17) | 0 | 0 | 0 |
| III | 1 (1/3) | 4 (4/17) | 1 (1/6) | 12 (12/16) | 1 (1/2) |
| IV | 0 | 3 (3/17) | 3 (3/6) | 4 (4/16) | 0 |
| Number African American Patients (ratio) | 3 (3/3) | 7 (7/16) | 5 (5/6) | 0 (0/9) | 1 (1/2) |
| Number Caucasian Patients (ratio) | 0 (0/3) | 9 (9/16) | 1 (1/6) | 9 (9/9) | 1 (1/2) |
| Mean Age (SD) | 73.3 (13.1) | 57.4 (10.5) | 68.2 (9.6) | 56.9 (8.7) | 60 (2.82) |
| Average SBK4 staining (SE) | 13.9 (3.1) | 23.4 (2.3) | 26.9 (6.6) | 44.0 (8.05) | 29.0 (1.0) |